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Introduction
Permethrin toxicity is one of the most common cat 
toxicities reported by the Animal Poison Control Center 
(ASPCA) (Merola and Dunayer, 2006). Permethrin 
toxicity is also the most common toxicity cases 
reported in cats in Italy (Richardson, 2000; Giuliano 
and Nebbia, 2004; Caloni et al., 2012, 2014). The 
majority of feline permethrin intoxications are believed 
to be due to owners applying canine products. Exposure 
can also occur after oral ingestion or direct contact 
with treated dogs (Richardson, 2000). Pyrethrins are 
naturally occurring esters of chrysantheic acid and 
pyrethric extracted from the flowers of Chrisanthemum 
cinerariifolium. Pyrethroids are synthetic analogues of 
pyrethrins. Permethrin is a class I pyrethroid insecticide 
which was first described in 1973 (Meyer, 1999).
They act on sodium ion channels and keep them open 
for a longer period of time. As a consequence they cause 
repetitive discharging of the cell and clinical signs 
of toxicity. Permethrins are metabolized by hepatic 
microsomial esterases and oxidases. This is followed 
by hydroxylation and conjugation into glucuronides 
or sulphates, which are mainly eliminated in urine. 
Although the reason why cats are particularly sensitive 
to permethrins is not fully understood, a species-related 
deficiency in glucoronyl transferase pathway has been 
postulated. Acting primarily on central nervous system 
(CNS), clinical signs are characterized by tremors, 
muscle fasciculations, twiching, hypersalivation, 
mydriasis, pyrexia and in severe cases, seizures and 
coma (Meyer, 1999). Intravenous lipid emulsion (ILE) 
is an emerging treatment for certain lipophilic drugs 
(O’Brien et al., 2010; Fernandez et al., 2011; Gwaltney-
Brant and Meadows, 2012; Kaplan and Whelan, 2012; 
Kidwell et al., 2014). As permethrins are very lipophilic 
molecules (Sangester, 1997), ILE was supposed to be a 
potential treatment. Some cases about the use of ILE in 
permethrin intoxication in cats were reported (Haworth 
and Smart, 2012; Kuo and Odunayo, 2013; DeGroot, 
2014). General guidelines for treatment of permethrin 
intoxication in cats suggest the use of anticonvulsant 
drugs to control seizures or muscle fasciculations, 
dermal decontamination with lukewarm water and the 
use of methocarbamol, as well as a centrally acting 
muscle relaxant to treat tremors (Schildt and Jutkowitz, 
2009). Alpha2 (α2) agonists have been used in veterinary 
medicine since the mid-80’. The sedative effect of α2 
agonists is due to the inhibitory action on the major 
noradrenergic nucleus in the brainstem, locus ceruleus. 
Their muscle relaxant effect is well known in animals 
(Lemke, 2007) and their use revealed helpful, in these 
specific cases reported.
In this report we evaluated the association of ILE 
and dexmedetomidine (DXMDT) for the treatment of 
permethrin intoxication in 4 cats.
Case 1
A 5-year-old, 2.5 Kg, spayed female, domestic European 
short hair cat, was presented for twitching and muscle 
tremors after the owner applied a topical permethrin flea 
product containing 1 gr/Lt imidacloprid and 500 g/Lt 
of permethrin in a 1 ml pipette (Advantix spot-on for 
4-10 kg dogs. Bayer AG, Leverkusen, Germany) 2 hours 
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Abstract
Four cases of feline permethrin intoxication are described. The cause of intoxication is the application of canine 
permethrin spot-on product (Advantix®, Bayer) by the owners. Principal clinical guidelines recommends the use of 
anticonvulsant drugs to treat seizures or neurological symptoms after initial stabilization and dermal decontamination. 
The use of lipid emulsion had an increasing interest in the last decade for treatment of toxicosis caused by lipophylic 
drugs as reported in human and in veterinary medical practices. All cats presented in this study, were treated with 
intravenous lipid emulsion (ILE) at variable dosages, and dexmedetomidine was also administered by intravenous 
way. No adverse reaction such as thrombophlebitis, overload circulation or others was noticed during and after 
administration of ILE. Dexmedetomidine was proved to be helpful in tranquillizing the cats. All cats were discharged 
in good condition faster than other cases treated without their use.
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prior to presentation, for a total toxic dose of permethrin 
of 200 mg/kg. At presentation the cat was tachypnoic 
(respiratory rate of 52 breaths per minute), heart rhythm 
was 128 beats per minute, oral membranes were pink 
and rectal temperature was 38.5°C (Table 1). The cat 
was depressed and indifferent and had convulsions 
after few minutes (Table 2). Cat was washed with a 
mild detergent and two endovenous catheters were 
placed at both cephalic veins. Micro-Hct and total 
protein were evaluated (Table 3). Ringer lactate solution 
infusion was started at 3 times the maintenance dose 
(6 ml/kg/h) for maintaining hydration and promote 
diuresis. Due to the severity of tremors, a single IV bolus 
of propofol (Proposure 10 mg/ml solution, Merial Italia, 
Milano- Italy) was given at 1 mg/kg. Then DXMDT 
(Dexdomitor 0.5 mg/ml solution for dogs and cats. Orion 
Corporation, Espoo, Finland) was administered IV at 
1 μg/kg. After administration cat was quieter and tremors 
were reduced. Oxygen was given via face mask and it 
was well tolerated. ILE (Intralipid 20% IV Fat Emulsion, 
Fresenius Kabi, Canada) bolus was administered using 
the second venous access at 2 ml/kg in 3 minutes, 
followed by a constant rate infusion at 4 ml/kg/h for 
one hour. After the first hour the cat was reassessed and, 
because of persisting twitching, ILE infusion continued 
again for 2 hours. Two hours later facial twitching 
reduced, respiratory rhythm slowed to 40 bpm and 
rectal temperature reduced to 37.9 °C. As the cat was 
not able to stand up, still unresponsive to surrounding 
stimulus, with mild tremors, ILE infusion was still 
continued for another 2 hours at 2 ml/kg/h, for a total 
time of 5 hours (Table 4). After this time neurological 
symptoms improved and temperature, heart rate, mucous 
membranes were within normal limit. Little facial 
twitching was still present and the animal was ataxic. On 
day 2 the cat still presented facial twitching, presented 
mild ataxia no tremors were observed and the animal was 
alert and eating without any problems. In the afternoon 
of the same day the cat was discharged after 26 hours 
after presentation. During hospitalization the cat also 
received: amoxicilline and clavulanic acid (Synulox 
injectable suspension, 140 mg/ml amoxicilline+ 
35 mg/ml clavulanic acid, Pfizer Italia Srl, Rome-Italy) 
at 12.5 mg/kg and ranitidine (Ranitidine 50 mg/5ml 
injectable solution, HEXAL S.p.a, Agrate Brianza (MB), 
Italy) at 2 mg/kg. Cat was discharged with antibiotic 
therapy (amoxicilline and clavulanic 12.5 mg/kg for a 
week). On follow-up for 10 months later, the owner had 
not noticed any abnormalities and the cat was well.
Case 2
A 14-year-old, 5 Kg female spayed European domestic 
short hair cat presented to Veterinary Teaching 
Hospital for lameness, muscle fasciculation, tremors 
and hypersalivation. A 25 ml pipette of Advantix, 
containing 250 mg of imidacloprid and 1250 mg of 
permethrin, was applied by the owner half an hour prior 
the presentation at clinical examination; for a toxic dose 
of 250 mg/kg. The cat was referred by colleagues that 
Table 1. Vital signs of the four cats at the arrival in the 
emergency department.
Cats HR (bpm) RR (Bpm) MC MRT (sec) RT (°C)
Cat 1 128 52 Pink <2 38.5
Cat 2 140 48 Pale <2 39.2
Cat 3 160 40 Pink <2 <33
Cat 4 200 70 Pale <2 37.7
bpm: Beats per minute; Bpm: Breaths per minute; 
sec: Seconds; °C: Celsius.
Table 2. Incidence of main neurological signs in four cats.
Neurological signs Cat affected
Convulsions C1, C3
Twitching C1, C2, C4
Tremors C1, C2 (still present after 24 h), C3
Salivation C2, C3
Ataxia C2, C3 (after 24 h)
Mydriasis C4
Muscle fasciculations C3, C4
Hypothermia C3
Tachypnoea C1, C2, C3, C4
C: Cat.
Table 3. Minimum emergency data base performed at arrival 
for treated cats.
Parameters C1* C2 C3 C4 References 
values
Hct (%) 37 33.8 17.8 28.3 37.0-55
TP (g/dL) 6.5 6.4 8 7 5.8-7.8
Alb (g/dL) “n/a” 2.7 2.6 “n/a” 2.6-4.1
Glucose (mg/dl) “n/a” 291 118 94 80-125
Alt (U/I) “n/a” 41 46 68 20-70
Crea (mg/dl) “n/a” 1.5 1.3 1.4 0.6-1.5
PH “n/a” 7.28 7.39 7.32 7.28-7.41
Na+ (mEq/L) “n/a” 148 148 158 146-156
K+ (mEq/L) “n/a” 4.7 2.5 3.9 3.9-5.5
Cl− (mEq/L) “n/a” 116 113 121 109-123
Hco3− (mEq/L) “n/a” 19 20.4 20 22-27
Lac (mmol/L) “n/a” 1.1 0.5 1.8 0.5-2.5
Presence of 
lipemia
No No Yes Yes
*Not performed due to financial limits. Hct: Haematocrit; 
TP: Total Protein; Alb: Albumine; Alt: Alanine Amino 
Transferase; Crea: Creatinine; Lac: Lactate; “n/a”: not 
available; C: Cat.
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received the animal after one hour from intoxication and 
administered diazepam at 1 mg/kg by endorectal way. At 
our examination, the cat was indifferent and presented 
severe tremors (Table 2). Vital signs are reported in 
Table 1. We proceeded at dermal decontamination with 
dishwashing liquid. Emergency data base was performed 
(Table 3). DXMDT at 10 μg/kg was administered by 
intramuscular way. After administration, tremors were 
considerably reduced and oxygen via face mask was 
given. Two endovenous catheters in cephalic veins 
were placed. Ringer lactate solution was commenced 
at 25 ml/h. ILE bolus was administered at a dosage 
of 1 ml/kg in 5 min. Then constant rate infusion at 
dosage of 5 ml/kg/h was started. Cat was monitored 
hourly. Tremors and fasciculations were still present 
after 2 hours from the beginning of the infusion and 
cat had seizures. Phenobarbital (Luminale®: Luminale 
200 mg/ml solution, Bracco S.p,a, Milano, Italy) at 
2 mg/kg I/M was administered. After 3 hours twitching 
and tremors reduced and the ILE infusion was reduced 
at 2 ml/kg/h. After 6 hours neurological signs improved 
and CRI of ILE was stopped (Table 4) and gross 
lipemia was detected via mHct Tubes (Table 3). The cat 
was alert but ataxic and only very fine tremors of the 
ears were still discernible on close inspection. During 
hospitalization cat also received: ranitidine at 2 mg/kg 
IV. On day 2 the cat was successfully discharged and 
no additional doses of anticonvulsant drug were used. 
On follow-up for 12 months later, the owner had not 
noticed any abnormalities and the cat was well.
Case 3
A 2-years old, 3 Kg male intact European domestic 
short hair cat was referred to the Veterinary Teaching 
Hospital for muscle fasciculations and tremors. The 
morning before the owner applied a permethrin 
spot on product containing 1 gr/Lt imidacloprid and 
500 g/Lt of permethrin in a 1 ml pipette (Adantix spot-on 
for 4-10 kg dogs. Bayer AG, Leverkusen, Germany), for 
a toxic dose of permethrin of 167 mg/kg. The cat had 
convulsions and was taken to the nearest Veterinary 
Centre. The cat was treated by colleagues with diazepam 
(Valium 10 mg/5 ml solution, ROCHE Italia S.p.a., 
Milano- Italy) IV (dosage was not reported) in bolus 
and propofol (Proposure 10 mg/ml solution, Merial 
Italia, Milano- Italy) at 1 mg/kg IV every 3 hours in 
the afternoon. The animal continued to have muscle 
tremors and didn’t ameliorate and was referred in the 
evening to our hospital after 21 hours from permethrin 
administration. At clinical presentation, the cat was 
unresponsive and presented with a severe hypothermia 
(in the first hour non detectable, < 33 °C - Table 1), with 
muscle fasciculations and severe tremors (Table 2). We 
proceeded to give oxygen via face mask at 5 Lt/min 
and we started to warm the cat. Emergency data was 
then collected (Table 3). Ringer lactate at 18 ml/h was 
administered and infusion rate was then adjusted hourly 
on the base of evaluation of perfusions parameters (Heart 
rate, pressure, quality of pulse, mucosal colour and 
refilling time). Midazolam (Midazolam 5 mg/ml solution, 
Roche S.p,a, Milano, Italy) bolus at 0.3 mg/kg IV was 
administered. A second venous catheter was placed in the 
other cephalic vein. A bolus of ILE at 2 ml/kg IV in 5 min 
followed by a CRI of 4 ml/kg/h was administered using 
the second vascular access. After 3 hours, the cat had 
still muscle fasciculations and tremors and temperature 
rise up to 37.8 °C. DXMDT (Dexdomitor 0.5 mg/ml 
solution for dogs and cats. Orion Corporation, Espoo, 
Finland) at 1 μg/kg IV followed by a CRI at 0.5 μg/kg/h 
was started. After 3 hours tremors ceased and ILE was 
discontinued. Only mild muscle fasciculations were 
still present and CRI of DXMDT was continued until 
the next morning (5 hours - Table 4). During infusion 
cat was monitored continuously by electrocardiogram. 
On day 2, the cat didn’t show a normal gag response 
Table 4. Dosages and time of administration of ILE (Intralipid 20%) and DXMDT (dexmedetomidine).
Cats ILE 
Bolus 
(ml/kg)
Time ILE 
bolus 
(min)
Rate of 
ILE CRI
Time 
CRI 
ILE (h)
DXMDT DXMDT 
CRI
Other drugs Days of 
hospitalization
Adverse 
effects 
observed
1 2 3 4 ml/kg/h 
for 3 h, 
2 ml/kg/h 
for 2 h
5 1 μg/kg IV No Propofol 1 mg/kg IV 1 None
2 1 5 5 ml/kg/h
For 3 h, 
2 ml/kg/h 
for 6
9 10 μg/kg IM No Diazepam 1 mg/kg ER
Phenobarbital 2 mg/kg IM
1 None
3 2 5 4 ml/kg/h 6 1 μg/kg IV 1 μg/kg/h 
for 6 h
Midazolam 0.3 mg/kg IV 4 Lipemia
+
4 2 5 2 ml/kg/h 4 10 μg/kg IM No Diazepam*
Phenobarbital 2 mg/kg IM
1 Lipemia
+
*Dosage unknown.
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and was ataxic. The evening of the day 2 the cat was 
able to eat, but was dysphagic and still ataxic. On 
day 4 the cat was discharged without complication 
with a hepatoprotective therapy. During hospitalization 
ranitidine at 2 mg/kg IV and amoxicilline and clavulanic 
acid (Synulox injectable suspension, 140 mg/ml 
amoxicilline+ 35 mg/ml clavulanic acid, Pfizer Italia 
Srl, Rome-Italy) at 12.5 mg/kg s/c was administered. On 
follow-up for 3 months later, the owner had not noticed 
any abnormalities.
Case 4
A 6-years-old, 3.5 Kg female spayed European domestic 
short hair cat was referred to Veterinary Teaching 
Hospital for twitching and muscle fasciculations. The 
owner divided the same pipette containing 250 mg of 
imidacloprid and 1250 mg of permethrin (ADVANTIX 
spot-on for 10-25 kg dogs. Bayer AG, Leverkusen, 
Germany) for a toxic dose of 119 mg/kg, to the coat of 
his three cats, but only this cat presented neurological 
symptoms. The cat was referred to our hospital after an 
initial evaluation by other colleagues that administered 
diazepam by endorectal way and DXMDT at 10 μg/Kg 
IM. At arrival, the cat was indifferent, had tremors and 
muscle fasciculations and showed a Horner syndrome. 
The cat was tachypnoic and tachycardic (Tables 1 and 2). 
Ringer lactate solution was commenced at 20 ml/kg/h 
and oxygen was administered via face mask. The cat 
was decontaminated with a lukewarm water bath and 
mild hand washing detergent. A second cephalic IV 
catheter was then placed and sample was collected 
for emergency data base (Table 3). A bolus of ILE 
(7 ml, 2 ml/kg) was then administered IV for over 
5 minutes followed by a constant rate infusion at rate 
of 2 ml/kg/h. The cat was revalued hourly and after 
3 hours tremors increased again and phenobarbital 
at 2 mg/kg I/M was then administered. ILE was 
discontinued after 4 hours due to the improvement 
of tremors and fasciculations (Table 4). On day 2, 
the cat was alert and the examination of intracranial 
nerves was good, normal gag response was present 
and the cat was ambulatory. The cat was eating without 
problem and was discharged the same day with a 
hepatoprotective therapy (Epato pasta DNR, Cremona, 
Italy) and amoxicillin and clavulanic acid (Synulox 
injectable suspension, 140 mg/ml amoxicillin+ 
35 mg/ml clavulanic acid, Pfizer Italia Srl, Rome-Italy) 
at 12.5 mg/kg for a week. During hospitalization 
the cat received ranitidine at 2 mg/kg IV and acetyl 
cysteine (Acetilcysteine 300mg/3ml solution, HEXAL 
S.p.a, Agrate Brianza (MB), Italy) at 70 mg/kg IV. On 
follow-up for 3 months later, the owner had not noticed 
any abnormalities.
Discussion
Permethrin toxicosis is a commonly reported poisoning 
in small animals in United States, UK, Australia and 
Italy (Merola and Dunayer, 2006; Caloni et al., 2012, 
2014). Most frequently, cats are intoxicated by owners 
by applying canine spot on products (Dymond and 
Swift, 2008). Cats are more likely than dogs to develop 
pyrethroid toxicosis. This is due to the feline liver being 
inefficient at glucuronide conjugation. Glucuronide 
conjugation is needed to metabolize permethrin. The 
low concentration products approved for cats contain 
0.05-0.1% of permethrin and do not seem to cause the 
signs that the concentrated (45-65% permethrin) canine 
spot-on do (MacDonald, 1995). Based on the public 
database of the American Society for the Prevention 
of Cruelty to Animals and ASPCA, ‘spot on’ product 
that contain permethrin which are labelled for use 
on dogs only, can result in serious toxicosis when 
applied on cats. Based on these cases, the application 
of product containing 100 mg/kg permethrin (1 ml of 
45% permethrin applied dermally on a 4-5 kg cat) can 
result in a life-threatening toxicosis. The minimum 
toxic dose is still unknown, but it would be expected 
to be lower. Cats should be considered more sensitive 
to permethrin compared with dogs, rats, or human; 
permethrin products formulated for dogs can contain 
up to 65% of permethrin, those formulated for cats 
less than 0.2%. All the cats that were presented for 
treatment received on average of 184 mg/kg. However 
there is no reported correlation between the amount of 
permethrin applied and the severity of clinical signs 
induced (Boland and Angles, 2010). No real antidote or 
antagonist is available and treatment recommendations 
include intravenous fluid support to maintain electrolyte 
balance and hydration and to promote diuresis, dermal 
decontamination with a mild detergent and luke 
warm water to prevent further absorption (Whittem, 
1995; Dymond and Swift, 2008). Every cat received 
a mean of 3 time maintenance of crystalloids, given 
intravenously as a bolus, followed by a reassessment 
of perfusion parameters (heart rate, quality of pulse, 
mucosal membrane colour). This is according to recent 
guidelines for emergency management of fluid therapy 
in the critical ill (Hopper et al., 2012) by which the 
use of ‘shock dose’ (60 ml/kg for cat and 90 ml/kg for 
dog) is abandoned. In emergency setting it is preferable 
to give a bolus intravenously in 15 or 20 minutes and 
then reassess the cat, giving some ‘end points’ for heart 
rate, mucosal membranes colour and refilling time in 
order to ameliorate tissue perfusion, diuresis, maintain 
systemic pressure and tissue oxygenation.
Intravenous fluids are also recommended to protect the 
kidney tubules from myoglobin breakdown products 
in cats with active seizures and tremors (Dymond and 
Swift, 2008; Linnett, 2008).
Seizure control can be achieved with diazepam, 
midazolam, barbiturates, propofol or inhalation 
anesthesia (Martin and Campbell, 2000; Linnett, 2008; 
Boland and Angles, 2010). Methocarbamol is also 
reported to reduce tremors and muscle fasciculations 
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(Meyer, 1999; Linnett, 2008).
In the last decade an increasing amount of evidence 
supports the use of ILE to reverse or attenuate the 
clinical manifestations of many lipophilic toxins 
(Rosenblatt et al., 2006). Permethrins are very 
lipophilic compounds, with a lipid solubility (log P) of 
6.5 (Sangester, 1997) and ILE would be expected to be 
an efficacious treatment. The mechanism of action is 
still unknown, but several theories have been proposed. 
One of the mechanisms is based on the possibility that 
a serum lipid partition creates a concentration gradient 
that facilitates the passage of toxicants from the 
interstitial tissue, decreasing their availability in target 
tissues as demonstrated in bupivacaine intoxication 
(Weinberg et al., 1998). Many case series regarding 
the use of ILE in feline permethrin intoxication have 
been reported (Haworth and Smart, 2012). Dosage of 
intravenous boluses or continuous infusion of lipids 
have not been assessed in animals for treatment of drug 
toxicity. In rats, the LD50 for rapid high volume lipid 
infusion was estimated to be 67 ml/kg (Johnson, 2011). 
In our study the amount of ILE administered was 
18 ml/kg for cat 1 (45 ml); 28 ml/kg for cat 2 (140 ml); 
26.3 ml/kg for cat 3 (79 ml); 10 ml/kg for cat 4 (35 ml). 
The LD50 reported in the study for rats, far exceeds from 
dosages we used and was obtained by experimental 
studies and for high rapid volume of infusion.
We should consider that a larger volume of ILE 
was used in cat 2, in which clinical symptoms were 
more severe. Previous recommendation reported 
a dose of 1.5 ml/kg as a bolus of ILE followed by a 
continuous infusion of 0.25 ml/kg/min (15 ml/kg/h) for 
30-60 min. (Fernandez et al., 2011). As appended in 
previous studies (Brϋckner and Scwedes, 2012; Kuo 
and Odunayo, 2013) it is not reported the use of the 
same dosage and rate of infusion of ILE for all the cats 
treated. Authors used different doses and rate of CRI 
for ILE. In our cases, especially for the rate of infusion, 
this could be related to a different adjustment of dosage 
in relation to the improvement of neurological clinical 
symptoms (reduction of tremors, twitching). We have to 
also consider that we collected the data retrospectively, 
and this could in part explain why for example cat 2, 
received a bolus of 1 ml/kg instead of 2 ml/kg as the 
others cats, considering however a range of 1-2 ml/kg 
as initial bolus. Different dosages have been used based 
on human recommendations or on the veterinary 
guidelines of parenteral nutrition. In agreement with 
Brϋckner and Scwedes (2012), we opted for a bolus of 
2 ml/kg (except for cat 2) followed by a mean rate of 
CRI of 4.25 ml/kg/h in all the treated cats. In the present 
case series a slow rate of infusion (2-5 ml/kg/h) for a 
longer time (max 9 hours for cat 2) seemed to be more 
effective in controlling muscle fasciculations, without 
risks of repeated venous line handling, reported in 
other case reports (Kuo and Odunayo, 2013). To reduce 
this complication to minimum we placed a dedicated 
intravenous catheter (20 gauge), in all the treated cats. 
Despite Brϋckner and Scwedes (2012), we placed 
a peripheral catheter as the osmolarity of the lipid 
emulsion was compatible with the size of the catheter 
(Intralipid 20%, Deerfield (Il): Baxter Healthcare 
Corporation; 2000). None of the cats showed any 
phlebitis, infection or cutaneous hyperaemia at the 
site of infusion. In a critical case, the shock status, 
with a consequent reduction of perfusion and tissue 
oxygenation, the presence of an oxidative stress, 
could result in a reduction of the efficiency of immune 
system. There are many reports in human medicine 
and experimental studies made on rats and dogs 
that argue about the possibility that ILE promotes 
lymphocyte and neutrophil death that may enhance the 
susceptibility of the patients to infections (Waitzberg 
et al., 2002; Cury-Boaventura et al., 2006; Kang and 
Yang, 2008). For these reasons we retain that the use 
of antibiotics in these cases could reduce or could help 
to reduce and prevent an eventual infection. However, 
the guidelines for peripheral parenteral nutrition in 
companion animals (Chandler et al., 2000) suggested 
the possibility for using a peripheral venous access 
with a maximum of 600 mOsm/Lt of the solution 
administered and the osmolarity of the ILE we used 
(Lipofundin®) is of 280 mOsm/Lt.
At present, the maximum daily dosage of intravenous 
lipids in veterinary patients is still unknown. Previous 
authors suggested to check for gross lipemia via micro-
Hct tubes, before administrating additional doses 
(Johnson, 2011). In our study we evaluated the degree 
of lipemia by serum observation, and only two cases 
showed a lipemic serum. However, no other side effects 
(hypersensivity, pulmonary oedema, thrombophlebitis) 
were noticed. Anyway the ideal dose and frequency 
for ILE administration has not been determined and 
warrants further study. Because of the low number 
of cases, it is difficult to say if the total volume of 
ILE varied in relation of anticonvulsant drugs or 
DXMDT. In all the treated cats, we tried to reduce 
at minimum the use of anticonvulsant drugs because 
authors preferred to use as soon as possible ILE as a 
part of the decontamination protocol. Comparing with 
retrospectives studies (Dymond and Swift, 2008; Boland 
and Angles, 2010) our four cats recovered faster, with 
a mean treatment time of 6 hours. A retrospective study 
(Boland and Angles, 2010) describes feline permethrin 
intoxication in 42 cases. In common of this report, we 
have the lack of availability of methocarbamol, but the 
main difference is the reduction of time of recovery 
and hospitalization in our study. In the Boland and 
Angles (2010) study, despite the use of anticonvulsant 
drugs such as midazolam used in CRI or propofol, they 
reported a mean of duration of tremors of 35 h with a 
median of duration of midazolam CRI of 38.5 h. They 
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also needed to intubate 12 cats because of respiratory 
depression caused by propofol used in CRI (for a 
median time of 23 h). They recorded the hospitalisation 
time for 34 cats and it was 3 days in average.
In our study, we didn’t need to intubate the cats, 
with all those complications deriving from that 
procedure (general anesthesia, possibility of aspiration 
pneumonia, the need of change the monitoring etc.); all 
our cats were discharged the day after, except for one 
cat that was discharged at day 4, due to the owner’s 
availability; although he was clinically stable and ready 
to go home 24 hours after presentation.
In feline permethrin intoxication, hematology and 
biochemistry panels are usually without abnormal 
finding (Talcott, 2009; Boland and Angles, 2010) except 
for stress-related responses such as hyperglycemia 
(as we found in cat 2) and neutrophilia (Bottcher 
et al., 2006; Linnett, 2008). Bottcher et al. (2006) 
also reported an increase in hematocrit and blood 
urea nitrogen. Long lasting seizure activity causes 
myoglobinuria which may lead to acute kidney injury 
(Dymond and Swift, 2008; Linnett, 2008). In our cases 
we find two cats (3 and 4) that showed low values of 
hematocrit at the entrance in emergency room and 
the other two with values in the ranges. This could be 
related to the fact that cats 3 and 4 were brought to us 
from other institutions and they received intravenous 
fluids before presentation to our hospital. Cat 3 was 
referred after 21 hours from intoxication; we can also 
hypothesize that it could be related to the oxidative 
stress or administration of propofol in CRI which can 
cause anemia with Heinz bodies in cats. In our cases, the 
rest of values were within normal range. We observed a 
moderate hypokaliemia for cat 3 (2.5 mEq/Lt). Among 
the causes reported of hypokaliemia (renal potassium 
wasting, diuretics drugs, severe diarrhea) it’s reported 
that an increased level of catecholamines could 
determine a disorder of internal balance (redistribution) 
that results in a decrease of the cation (Riordan and 
Schaer, 2009). In addition to that, cat 3 had a very 
severe salivation.
At present there are no practical diagnostic tests 
available to confirm permethrin intoxication. Many 
others toxic agents and also medical conditions 
like trauma, hypocalcemia, hypoglicemia, hepatic 
encephalopathy and encephalitis should be ruled out 
(Whittem, 1995; Linnett, 2008; Boland and Angles, 
2010).
As mentioned above, methocarbamol is a drug 
classically used to treat tremors in feline permethrin 
intoxication. The use methocarbamol, alone or 
in addition to anticonvulsant drugs is available 
intravenously or orally. Methocarbamol is a centrally 
acting muscle relaxant. At time of our study, in Italy 
and other European countries this drug was not 
available. As a consequence we opted for the use of 
anticonvulsants as diazepam, midazolam or propofol. 
Benzodiazepines produce most of their pharmacological 
effects by modulating gamma-aminobutyric acid 
(GABA)-mediated neurotransmission (Tanelian 
et al., 1993); two main types of GABA receptors 
are involved in neuronal transmission: GABAA and 
GABAB. The benzodiazepines-binding site is located in 
GABAA receptor complex and its activation increases 
chloride conductance and generates slow inhibitory 
postsynaptic potentials. This is one of the mechanism 
that promotes muscle relaxant and sedative effects. 
Permethrin act as antagonist of the GABA receptor by 
reducing the GABA-stimulated chloride ion flux. This 
anti-inhibitory action could lead to hyperexcitability 
and contribute to or exacerbate some clinical signs 
(Whittem, 1995). For these reasons, in accordance with 
previous studies, we decided to use these drugs.
According to Löscher et al. (2002), methocarbamol 
is not recommended in cats due to possible side 
effects. In a case series of Dymond and Swift (2008), 
rectal or oral use of methocarbamol was reported; 
there was no difference in the duration of treatment 
of methocarbamol-treated cats compared with those 
receiving only diazepam or propofol. The only 
noticed difference was the fact that cats treated with 
methocarbamol did not require any further treatment 
with diazepam or propofol (Dymond and Swift, 2008).
According to the Authors’ knowledge this is the first 
case series in which ILE has been associated with 
an α2 agonist drug. Alpha2 agonists are well studied, 
known and used in veterinary medicine since the 
mid-80’s. Sedative effect of α2 agonists is due to the 
inhibitory action on the major noradrenergic nucleus 
in the brainstem, locus ceruleus. Their muscle relaxant 
effect is well known in animals (Lemke, 2007) and its 
neuroprotective and cardioprotective effects have been 
also documented, as well as their positive effects on 
cerebral blood flow in human neuroanesthesia (Farag 
et al., 2011).
DXMDT is the pharmacologically active isomer 
of medetomidine, with several advantages, such as 
reversibility, lower possibility of interaction with 
other drugs used and lower hepatic metabolism 
(Kuusela et al., 2000). Variable dosages are suggested 
in literature for its use. The dosages we used, were in 
agreement with most reports (Anash et al., 2000) and 
derived by Authors’ clinical experience and confidence. 
When DXMDT is administered intramuscularly, 
higher dosage is recommended; in accordance with 
previous studies we opted for using large dose by 
intramuscular way in order to obtain a good sedation 
and muscle relaxant effect (cats 2 and 4: administered 
by colleagues: 10 microgram/kg vs 1 microgram/kg 
IV for cats 1 and 3). After the administration of single 
bolus, cats became calmer and tremors were reduced. 
This resulted in a reduction of stress and facilitated 
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the possibility to manipulate the animals, to give them 
oxygen or others medicaments. It is known that in 
permethrin intoxication a quiet environment, silence 
and darkness are recommended. DXMDT revealed 
helpful for the management of the animals, reducing 
the restrain and the stress; cats are less scared and more 
collaborative. In addition to that, DXMDT allows to 
asses neurological function (examination of intracranial 
nerves, spinal reflexes) due to its reversibility, even 
stimulating the animal. In one cat we used a constant 
rate infusion of DXMDT to achieve a longer effect of 
sedation and tranquilization. To our knowledge there are 
no reports in literature about the use of DXMDT CRI 
as adjunctive therapy in feline permethrin intoxication 
and only few reports about the use of continuous 
infusion of this drug in the cat (Anash et al., 2000). 
However, further investigations are needed to evaluate 
the efficacy of DXMDT in the feline patient.
All drugs we used, such as benzodiazepines (diazepam, 
midazolam), propofol and DXMDT are lipophilic. 
The lipophilicity of a substance may be measured 
by the partition coefficient (P), which is a ratio of 
the distribution of a substance between 2 liquids that 
are incapable of mixing, such as water and octanol 
(Sangester, 1997). The logarithm of P is reported to 
describe lipophilicity, the higher the Log P value, the 
more lipophilic a drug become. Drugs are determined 
to be lipophilic if their log P>1.0.
One can suppose that the use of ILE may affect the 
availability of other lipophilic drugs administered, 
such as mentioned above and also in the case of 
use of methocarbamol. If we consider the Log P 
for DXMDT (Log P 2.8) midazolam (Log P 3.3), 
phenobarbital (Log P 1.47) diazepam (Log P 2.82) 
and propofol (Log P 3.8), given that permethrin is 
even more lipophilic with a Log P of 6.5 (Sangester, 
1997), it would be expected that ILE be efficacious 
for the treatment of feline permethrin toxicosis and 
theoretically should have minimal effects on the use 
of that drug or methocarbamol (Log P 0.55). The cases 
described illustrate no appreciable negative effects 
using ILE in conjunction with DXMDT. The clinical 
effect we observed after its administration (sedation, 
muscle relaxation) it’s not far different from that we 
observed when we used the drug as a sedative in 
anesthesia section without ILE. We can assume that 
it could probably depend from the lipophilicity of 
the substance, but also from the dosage one uses. We 
don’t know if the prospect of increasing the dose of 
lipophilic drugs such as dexmedetomine may need 
to be considered when used in conjunction with ILE, 
even if the Log P respect to the permethrin one is quite 
lower. DXMDT produce an excellent sedation and 
promote a neurological status similar to physiological 
sleep (Serafim et al., 2015). This effect in addition 
to the muscle relaxant effect, promotes the reduction 
of tremors and the reduction of cerebral oxygen 
consumption and metabolism by reducing cerebral 
blood flow (Zornow et al., 1993).
ILE seemed to be well tolerated and no adverse effects 
were noticed. A shorter time of hospitalization and 
reduced cost of recovery were reported. Although 
we tried to use standardized dosages and protocols 
for all cases, the use of ILE is not recommended as a 
single treatment, without any further seizure control 
or supportive care. In the present study, DXMDT 
appeared to be useful as a sedative and muscle relaxant 
for affected cats, particularly in the early phases of 
treatment. We hypothesize that DXMDT could be 
considered as a replacement in those cases in which 
other medicaments considered ‘elective’ for treatment 
of permethrin intoxication, such as methocarbamol, are 
not available.
A prospective and controlled clinical trial should be 
performed in order to validate the use of DXMDT as 
a part of the emergency protocol for feline permethrin 
intoxication.
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